MITOCHONDRIA, CHOLESTEROL AND AMYLOID BETA PEPTIDE: A DANGEROUS TRIO IN ALZHEIMER DISEASE
MITOCHONDRIAL S-ADENOSYL-L-METHIONINE TRANSPORT IS INSENSITIVE TO ALCOHOL-MEDIATED CHANGES IN MEMBRANE DYNAMICS.
THERAPEUTIC TARGETS IN LIVER TRANSPLANTATION: ANGIOTENSIN II IN NONSTEATOTIC GRAFTS AND ANGIOTENSIN-(1-7) IN STEATOTIC GRAFTS
EPC adhesion to arteries from diabetic and non-diabetic patients: effect of pioglitazone.
CATHEPSINS B AND D DRIVE HEPATIC STELLATE CELL PROLIFERATION AND PROMOTE THEIR FIBROGENIC POTENTIAL
DEFECTIVE IL-10 PRODUCTION IN SEVERE PHENOTYPES OF CROHN'S DISEASE
METHILMERCURY DISRUPTS THE BALANCE BETWEEN PHOSPHORYLATED AND NON-PHOSPHORYLATED COFILIN IN PRIMARY CULTURES OF MICE CEREBELLAR GRANULE CELLS A PROTEOMIC STUDY
MITOCHONDRIAL GLUTATHIONE, A KEY SURVIVAL ANTIOXIDANT.
THE REG4 GENE, AMPLIFIED IN THE EARLY STAGES OF PANCREATIC CANCER DEVELOPMENT, IS A PROMISING THERAPEUTIC TARGET
El splicing alternativo de H-Ras en mamíferos une varios factores de splicing a procesos cancerígenos.
Tissue plasminogen activator induces pancreas cancer cell proliferation by a non-catalytic mechanism that requires ERK1/2 activation through Epidermal Growth Factor Receptor and Annexin A2
"UPREGULATION OF CCAAT/ENHANCER BINDING PROTEIN BETA IN ACTIVATED ASTROCYTES AND MICROGLIA."
''DISTRIBUTION OF CLOSTRIDIUM PERFRINGENS EPSILON TOXIN IN THE BRAINS OF ACUTELY INTOXICATED MICE AND ITS EFFECT PON GLIAL CELLS.''
''CCAAT/ENHANCER BINDING PROTEIN ALPHA IS DOWNREGULATED BY TOLL-LIKE RECEPTOR AGONISTS IN MICROGLIAL CELLS.''
Trimethylguanosine nucleoside inhibits cross-linking between Snurportin 1 and m3G-capped U1 snRNP
Tissue plasminogen activator mediates amyloid induced neurotoxicity via sustained Erk1/2 activation.
The tissue plasminogen activator system in murine exocrine pancreas cancer:selective expression in ductal tumors and contribution to cancer progression.
New insights into the tPA-Annexin A2 interaction: is Annexin A2 Cys8 the sole requirement for this association?
Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein which trafficks to cytoplasm and nucleus.
HnRNP A1 and SR proteins regulate the alternative splicing of proto-oncogen c-H-ras, balancing the relative abundance of two alternative H-Ras proteins, p19 and p21.
